IL100765A - Antiviral vaccine with synergistic effect containing as an adjunct to the virus core of influenza - Google Patents

Antiviral vaccine with synergistic effect containing as an adjunct to the virus core of influenza

Info

Publication number
IL100765A
IL100765A IL10076592A IL10076592A IL100765A IL 100765 A IL100765 A IL 100765A IL 10076592 A IL10076592 A IL 10076592A IL 10076592 A IL10076592 A IL 10076592A IL 100765 A IL100765 A IL 100765A
Authority
IL
Israel
Prior art keywords
core
vaccine
protein
additive
composition according
Prior art date
Application number
IL10076592A
Other languages
English (en)
Hebrew (he)
Other versions
IL100765A0 (en
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9409015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL100765(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of IL100765A0 publication Critical patent/IL100765A0/xx
Publication of IL100765A publication Critical patent/IL100765A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10076592A 1991-01-24 1992-01-24 Antiviral vaccine with synergistic effect containing as an adjunct to the virus core of influenza IL100765A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100806A FR2671974A1 (fr) 1991-01-24 1991-01-24 Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.

Publications (2)

Publication Number Publication Date
IL100765A0 IL100765A0 (en) 1992-09-06
IL100765A true IL100765A (en) 1996-06-18

Family

ID=9409015

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10076592A IL100765A (en) 1991-01-24 1992-01-24 Antiviral vaccine with synergistic effect containing as an adjunct to the virus core of influenza

Country Status (10)

Country Link
EP (1) EP0522138B2 (enrdf_load_stackoverflow)
AT (1) ATE234861T1 (enrdf_load_stackoverflow)
AU (1) AU654699B2 (enrdf_load_stackoverflow)
CA (1) CA2078985C (enrdf_load_stackoverflow)
DE (1) DE69232962T3 (enrdf_load_stackoverflow)
FR (1) FR2671974A1 (enrdf_load_stackoverflow)
IL (1) IL100765A (enrdf_load_stackoverflow)
NZ (1) NZ241398A (enrdf_load_stackoverflow)
WO (1) WO1992013002A1 (enrdf_load_stackoverflow)
ZA (1) ZA92510B (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019013A1 (en) * 1993-02-19 1994-09-01 Smithkline Beecham Corporation Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
WO1998046262A1 (en) * 1997-04-16 1998-10-22 Connaught Laboratories, Inc. Anti-influenza compositions supplemented with neuraminidase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
US5136019A (en) * 1989-05-24 1992-08-04 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
DE69232962T2 (de) 2005-06-23
ZA92510B (en) 1992-11-25
EP0522138B1 (fr) 2003-03-19
AU654699B2 (en) 1994-11-17
DE69232962T3 (de) 2007-11-08
CA2078985C (fr) 2004-11-09
FR2671974A1 (fr) 1992-07-31
AU1248792A (en) 1992-08-27
NZ241398A (en) 1994-08-26
WO1992013002A1 (fr) 1992-08-06
CA2078985A1 (fr) 1992-07-25
EP0522138A1 (fr) 1993-01-13
IL100765A0 (en) 1992-09-06
FR2671974B1 (enrdf_load_stackoverflow) 1995-03-03
DE69232962D1 (de) 2003-04-24
ATE234861T1 (de) 2003-04-15
EP0522138B2 (fr) 2007-02-14

Similar Documents

Publication Publication Date Title
Bungener et al. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection
US6635246B1 (en) Inactivated influenza virus vaccine for nasal or oral application
Eliasson et al. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine
KR100703571B1 (ko) 인플루엔자에 대한 펩티드-기초 백신
KR960003378B1 (ko) 백신 제제
US6485729B1 (en) Neuraminidase-supplemented compositions
Elvander et al. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses
AU5720099A (en) Novel influenza virus vaccine composition
CN102078606B (zh) 一种呼吸道合胞病毒体疫苗及其制备方法
Webster et al. Matrix protein from influenza A virus and its role in cross-protection in mice
Potter et al. A new surface-antigen-adsorbed influenza virus vaccine II. Studies in a volunteer group
US20100196495A1 (en) Delivery of flu antibodies to surfaces in contact with air
US5741493A (en) Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive
US6921543B2 (en) Immunomodulatory preparation
CN109180784B (zh) 一种促进禽流感和/或新城疫疫苗的免疫反应的法氏囊活性六肽及应用
Glück Intranasal immunization against influenza
AU654699B2 (en) Influenza virus vaccine composition having a synergistic effect and containing influenza virus core as an additive
EP4316515A1 (en) Influenza vaccine
Webster et al. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)—a new equine influenza virus
WO1997041891A1 (en) Compositions and methods for protection against immunologically diverse isolates of influenza virus
CN102526722A (zh) 人用狂犬疫苗
AU2001293477B2 (en) Immunomodulatory preparation
US20150174236A1 (en) Viral vaccine and process for preparing the same
Potter et al. Immune response of mice to immunization with subunit influenza A vaccine in DTP vaccine
T Kheiri et al. Protective Immunity in Mice Following Immunization with the Cochleate-Based Subunit Influenza Vaccines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired